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Background: Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) allows selective replacement of the
endothelium. Post-operative haze and particles can affect the interface quality and, ultimately, visual outcome. In
this study, we evaluated DSAEK interface with in vivo laser confocal microscopy (LCM) in order to: (i) correlate
interface status with best corrected visual acuity, and (ii) with time from surgery; (iii) correlate interface particle
number with best corrected visual acuity. Host-donor interface was imaged and graded using a published
reflectivity scale. Particles at the interface were counted.
Methods: 18 eyes of 16 patients (6 males and 10 females); mean age: 74 ± 8.3 years which underwent DSAEK were
examined by means of in vivo laser confocal microscopy between 1 and 24 months after surgery. Host-donor
interface was imaged and graded using a published reflectivity scale. Particles present at the interface were
counted.
Results: Interface reflectivity was 2.17 ± 1.2 and significantly correlated with visual acuity (Spearman correlation
coefficient −0.83; P < 0.001), and with time after surgery (Spearman correlation coefficient −0.87; P < 0.001). Visual
acuity was 0.67 ± 0.27. The number of particles was 205 ± 117.8; no correlation was found between this number and
visual acuity (Spearman correlation coefficient −0.41; P = 0.15).
Conclusion: DSAEK interface imaged with LCM is helpful in diagnosing poor host-donor interface quality in DSAEK
surgery. A good quality interface is related to a better visual acuity. Moreover, the quality of the interface appears to
improve as time passes from the surgery. Interface quality is related with visual acuity and improves with time from
surgery. LCM should be considered as an added tool in post-DSAEK follow-up of patients. Finally, our study shows
that the presence of particles does not influence visual outcome.
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Descemet Stripping Automated Endothelial Keratoplasty
(DSAEK) is a recently developed lamellar corneal trans-
plant which allows selective replacement of the endothe-
lial side of the cornea. It has been proposed as an
alternative to penetrating keratoplasty (PK) in cases of
dysfunctional endothelium [1-3]. DSAEK has gained in-
creasing popularity as it induces less post-operative
astigmatism, less high order aberrations, and encounters
higher patient satisfaction, when compared to PK [4].
Differently from PK, however, DSAEK creates a donor-
host interface which can cause significant haze and* Correspondence: giulio.ferrari@schepens.harvard.edu
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reproduction in any medium, provided the orpossibly influence visual recovery. Moreover, particles of
different nature (lint, cellular debris, plastic or metallic
particles) can be detected often times at the slit-lamp
and their possible impact on visual acuity has been ob-
ject of concern [5].
A new generation of in-vivo laser confocal microscopy
devices (Heidelberg Retina Tomograph 2 Rostock Cor-
nea Module; Heidelberg Engineering GmbH, Dossen-
heim, Germany) has become available recently [6-8].
These instruments provide histology-quality images,
without the need to remove, stain and cut the tissue,
with a higher axial resolution (4 μm) than that achieved
with white-light confocal microscopy (10 μm with Con-
foScan 2, Nidek Technologies, Vigonza, Italy). This case
series investigates the impact of interface reflectivity andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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points. Patients were consecutively enrolled during a
two-month time frame.
Methods
The ophthalmology department board approved this
study. Informed consent was obtained prior to perform-
ing confocal microscopy; the study followed the tenets
of the Declaration of Helsinki. 18 eyes of 16 patients (6
males and 10 females) who underwent DSAEK surgery
due to Fuchs’ dystrophy at the University Hospital of
Parma, Italy were included in the study. Patients were
proposed to join the study and the protocol was
explained.
Exclusion criteria for this study were glaucoma, ocular
infections and uveitis. Patients were imaged between 1
and 24 months following DSAEK surgery.
All patients underwent a complete ophthalmology visit
including refraction with determination of ETDRS-
measured Best Spectacle Corrected Visual Acuity
(BSCVA), biomicroscopy, intraocular pressure measure-
ment, and in-vivo scanning laser confocal microscopy
(LCM).
Patients underwent DSAEK surgery alone or asso-
ciated with cataract extraction (Table 1).
DSAEK surgery
All procedures were performed under monitored
anesthesia with peribulbar block, following a publishedTable 1 Demographics of the study population




1 83 M Fuchs′ DSAEK 1
2 56 M Fuchs′ DSAEK 0.8
3 78 F Fuchs′+ cataract DSAEK+ FACO+ IOL 0.6
4 72 F Fuchs′ DSAEK 0.8
5* 65 M Fuchs′+ cataract DSAEK+ FACO+ IOL 1
6* 65 M Fuchs′ DSAEK 0.8
7* 72 F Fuchs′ DSAEK 0.8
8* 72 F Fuchs′+ cataract DSAEK+ FACO+ IOL 0.8
9 77 M Fuchs′ DSAEK 1
10 85 F Fuchs′ DSAEK 0.6
11 69 F Fuchs′ DSAEK 0.8
12 82 F Fuchs′ DSAEK 0.4
13 78 F Fuchs′ DSAEK 0.13
14 77 F Fuchs′ DSAEK 0.4
15 83 F Fuchs′ DSAEK 0.2
16 68 F Fuchs′ DSAEK 1
17 85 M Fuchs′ DSAEK 0.4
18 65 M Fuchs′ DSAEK 0.6
Asterisks indicate eyes from the same patient (5, 6 and 7, 8).technique [9]. Briefly, donor lenticules were prepared
with a Moria artificial chamber, a Carriazo-Barraquer
microkeratome (300 μm microkeratome head), and a
punching block (Moria, Antony, France). The anterior
chamber of the recipient eye was then entered through a
4 to 5 mm clear corneal incision. An anterior chamber
maintainer was used to prevent anterior chamber col-
lapse during surgery. Descemet membrane was stripped
from the central 8 mm. The peripheral edge of the rolled
endothelial graft was grasped from a device inserted in
the corneal tunnel and pulled inside the anterior cham-
ber with either coaxial forceps or a Prolene 10–0 suture.
A small air bubble was injected to lift the donor tissue.
After centering the graft, the anterior chamber was com-
pletely filled with air. After 10 minutes, the air bubble
was reduced to about 80% of the size of the endothelial
graft.
In vivo confocal microscopy
All eyes were examined using the same LCM device
(Heidelberg Retina Tomograph 2 Rostock Cornea Mod-
ule; Heidelberg Engineering GmbH, Dossenheim, Ger-
many). Briefly, patients were instilled with a drop of
topical anesthetic (Oxybuprocaine chloridrate 0.4%) 5
minutes and immediately before the exam. The patient
was then asked to steadily fixate a target and LCM was
performed on the central cornea as we described previ-
ously [10]. The exam lasted approximately 10 minutes.
At the end of the examination, antibiotic ointment
(Ofloxacin 0.3%) was applied.
Examination was performed taking scans of the epithe-
lium, and progressively focusing to deeper layers down
to the interface area. Interface area was identified as the
acellular zone found proceeding from the epithelium to
the endothelium. This area hosted often times birefrin-
gent particles, as previously described (11). At least three
scans - chosen for image quality - were considered.
Images obtained were 400x400 microns wide. Particle
density was measured using a built-in software (Cornea
section cell count; Heidelberg Engineering), which calcu-
lates the density of objects manually selected by the op-
erator. In order to minimize variability, a single
investigator blinded to the patient group analyzed and
graded all the images retrospectively. Images were
graded following a published method specifically studied
for HRT2 confocal microscope [11]. The grading was
performed by comparing our images with sample images
provided by Kobayashi et al. We used a 4 grade scale
(grade 1: no haze; grade 4: severe haze).
Statistical analysis
Data analysis was performed using SPSS for Windows
(version 11.0, SPSS Inc, Chicago, Illinois). Correlation
was studied by means of Spearman Correlation
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nificant if the P value was <0.05, and highly significant if
P was <0.01.
Results and discussion
We examined 6 males and 10 females (16 patients, 18
eyes). The mean age was 74 ± 8.3 and ranged from 56 to
85 years. Table 1 provides the demographics of the study
population.
Interface reflectivity was 2.17 ±1.2 and significantly cor-
related with visual acuity (Spearman correlation coefficient
−0.83; P < 0.001), and with time after surgery (Spearman
correlation coefficient −0.87; P < 0.001); Figure 1 A and B.
Visual acuity averaged over all the patients was
0.67 ± 0.27. The number of particles was 205 ± 117.8. No
correlation was found between the number of particles
at the interface and visual acuity (Spearman correlation
coefficient −0.41; P = 0.15); Figure 1C.
Moreover, we did not find a significant correlation be-
tween the time from surgery and the number of inter-
face particles (Spearman coefficient 0.53, P = 0.06).
Interface quality assessment with slit-lamp and LCM
appeared consistent (Figure 2).
DSAEK surgery is considered a valuable alternative to
PK in cases of dysfunctional endothelium such as in
Fuchs’ dystrophy as it selectively replaces it. DSAEK is
less invasive and better tolerated by patients [4], allows
prompt improvement and stability of visual acuity. How-
ever, being a lamellar surgery, it creates an interface be-
tween the donor and the recipient tissue, where the
healing process is thought to be critical to optimal visualFigure 1 A. Negative correlation between interface reflectivity and BS
(Spearman correlation coefficient −0.83; P < 0.001) B. Negative correlation b
correlation coefficient −0.87; P < 0.001). The longer the time from surgery, t
between the number of particles at the interface and visual acuity (Spearmrecovery [11]. DSAEK grafts present increased haze at
least up to three months, when compared to PK grafts
[12]. Loss of corneal transparency and swelling in Fuch’s
dystrophy have been object of extensive studies [13].
The most common cause of DSAEK failures is second-
ary to endothelial cell loss, followed by “dysfunctional”
donor-host interface. These include lenticule dislocation,
interface fibrosis or hemorrhage, epithelial downgrowth
[14-16].
LCM is a low-invasivity, repeatable method which
allows to study the interface histology in vivo, and hence
is suitable to study the interface healing process.
Previous studies have evaluated the interface on a
smaller sample of patients, or at lower resolution with
white-light confocal microscopy. Our study shows a cor-
relation between visual acuity and interface grading.
Interestingly, the deep part of the stroma, where DSAEK
surgery takes place, is interested by a number of patho-
logical changes. For example, it has been shown that
fluid entering the cornea causes more swelling in the
posterior than in the anterior lamellae. Also, posterior
lamellae can reach higher degree of final hydration, and
collagen-free regions (known as “lakes”) exist in Fuch’s
dystrophy corneas which are thought to be caused by
dead cells and fibril disordering. The selective distribu-
tion of fluid into the corneal stroma might reflect a dif-
ferent glycosaminglycan concentration in the posterior
part of the cornea [13]. All these observations contribute
to explain the formation of an interface haze following
DSAEK, and corroborate a correlation between haze ex-
tent and visual acuity loss. To our knowledge, this is theCVA. The higher the interface reflectivity, the lower the visual acuity
etween interface reflectivity and with time after surgery (Spearman
he lower the interface reflectivity. C. No correlation was found
an correlation coefficient −0.41; P = 0.15).
Figure 2 Panel A. Representative slit lamp and confocal pictures of a low reflectivity (i.e. good quality) interface. Note the clear interface
observed at the slit lamp, which corresponds to a dark confocal image. The BSCVA in this patient was 20/20. Panel B. Representative slit lamp
and confocal pictures of a high reflectivity (i.e. poor quality) interface. Note the evident white line representing the donor-host interface (arrow),
which corresponds to a hazy confocal picture. The BSCVA in this patient was 20/40.
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confocal HRT2 measure and BSCVA. This finding is in
contrast with what previously reported by Espana et al.
[17], using a different microscope (ConfoScan as
opposed to HRT). However, caution should be used in
comparing these two studies, as the axial resolution pro-
vided by HRT is more than double than the ConfoScan,
and this could explain the different findings.
Similarly to others [17,18], we found no correlation
between particle number and visual acuity. Small parti-
cles located at the interface are a common finding fol-
lowing DSAEK, and are also observed after LASIK
surgery [19]. The origin of interface particles has been
object of research: they are generally thought to be asso-
ciated with the use of the microkeratome [20-22], but
they were also observed after femtosecond laser applica-
tion [23]. Although previous studies suggested a deleteri-
ous effect of particles on visual acuity [5], it is now
becoming clear that this may not be the case [17,18].
Our study confirms that small debris should not repre-
sent a concern to the surgeon. Interestingly, we did not
find any correlation between the particle number and
time from surgery (Spearman correlation coefficient
0.53, even though the P value (0.06) was not extremely
low). In contrast with this, Kobayashi et al. reported a
progressive reduction of particle number with time
[11,24]. Our findings could also be due to a difference in
the materials used and/or environment encountered
during the surgery and/or the relatively small size of our
sample. Similarly to other authors, we did not find acti-
vated keratocytes or dendritic cells at the interface
[11,17,24]. This could be due to either the low density of
these cells in the posterior stroma, or to the time passed
from surgery, which would allow keratocytes to become
quiescent.A correlation between interface grading and time form
surgery- suggested by this study- was confirmed by other
papers [11,24] implying that a healing process occurring
at the interface - an actual surgical wound in the cornea
- is associated with a progressive gain in visual acuity.
We would like to point out that this study also had
limitations. One of these is represented by the small
sample number; hence bigger samples would be needed
to confirm our findings. Secondarily, other potentially
useful outcomes such as topography and pachymetry
were not considered. We anticipate this may be the ob-
ject of future studies.
Conclusions
In the present study, we quantified the interface quality
following DSAEK surgery. We found that a good quality
interface is related to a better visual acuity, and
improves with time from surgery. Also, the presence and
number of particles imaged at the interface is not related
with visual outcome. We propose that in vivo LCM
could be a helpful tool in the follow-up of DSAEK
patients, as the study of the interface gives information
potentially relevant for major clinical outcomes (such as
BSCVA) together with other relevant information, such
as endothelial cell count and keratocyte activation status.
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